Cyclopentolate Hydrochloride and Insulin Glulisine (Vials)
Determining the interaction of Cyclopentolate Hydrochloride and Insulin Glulisine (Vials) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate ophthalmic
Brand name: Cyclogyl, Cylate, AK-Pentolate, Pentolair, Ocu-Pentolate
Synonyms: Cyclopentolate ophthalmic
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate Hydrochloride-Insulin glulisine Subcutaneous
- Cyclopentolate Hydrochloride-Insulin human inhaled Inhalation
- Cyclopentolate Hydrochloride-Insulin human regular Injection
- Cyclopentolate Hydrochloride-Insulin inhalation
- Cyclopentolate Hydrochloride-Insulin isophane
- Cyclopentolate Hydrochloride-Insulin isophane and insulin regular
- Insulin Glulisine (Vials)-Cyclopentolate ophthalmic
- Insulin Glulisine (Vials)-Cyclophosphamide
- Insulin Glulisine (Vials)-Cyclophosphamide Capsules
- Insulin Glulisine (Vials)-Cyclophosphamide Injection
- Insulin Glulisine (Vials)-Cyclophosphamide oral and injection
- Insulin Glulisine (Vials)-Cyclophosphamide Oral, Intravenous